Investment Analysts’ Recent Ratings Updates for Cardinal Health (CAH)

Cardinal Health (NYSE: CAH) has recently received a number of price target changes and ratings updates:

• 1/10/2025 – Cardinal Health had its price target raised by analysts at Citigroup Inc. from $120.00 to $129.00. They now have a “neutral” rating on the stock.
• 1/8/2025 – Cardinal Health was upgraded by analysts at TD Cowen from a “hold” rating to a “buy” rating. They now have a $144.00 price target on the stock, up previously from $130.00.
• 1/7/2025 – Cardinal Health was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating. They now have a $140.00 price target on the stock.
• 1/6/2025 – Cardinal Health was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $145.00 price target on the stock, up previously from $132.00.
• 12/17/2024 – Cardinal Health had its price target raised by analysts at Morgan Stanley from $127.00 to $136.00. They now have an “overweight” rating on the stock.
• 12/13/2024 – Cardinal Health was upgraded by analysts at Wells Fargo & Company from an “underweight” rating to an “equal weight” rating. They now have a $127.00 price target on the stock, up previously from $101.00.
• 12/4/2024 – Cardinal Health is now covered by analysts at Mizuho. They set an “outperform” rating and a $139.00 price target on the stock.

Cardinal Health Price Performance

Shares of Cardinal Health stock traded up $3.02 on Tuesday, reaching $123.88. 1,213,787 shares of the company traded hands, compared to its average volume of 2,031,581. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $126.23. The company has a 50 day moving average of $120.06 and a 200 day moving average of $111.23. The firm has a market capitalization of $29.98 billion, a PE ratio of 24.10, a PEG ratio of 1.47 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last released its earnings results on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The firm had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. During the same period in the prior year, the firm earned $1.73 EPS. The company’s revenue was down 4.3% compared to the same quarter last year. As a group, analysts anticipate that Cardinal Health, Inc. will post 7.82 earnings per share for the current year.

Cardinal Health Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be issued a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.63%. The ex-dividend date is Thursday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is presently 39.30%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Eastern Bank bought a new position in Cardinal Health in the 3rd quarter worth approximately $25,000. Frazier Financial Advisors LLC boosted its holdings in Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after buying an additional 104 shares during the period. Ashton Thomas Private Wealth LLC bought a new position in Cardinal Health in the 2nd quarter worth approximately $29,000. Hara Capital LLC bought a new position in Cardinal Health in the 3rd quarter worth approximately $31,000. Finally, AM Squared Ltd bought a new position in Cardinal Health in the 3rd quarter worth approximately $33,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.